Igor Vujic

Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression

Martina Sanlorenzo, Igor Vujic, Adil Daud et al. · JAMA Dermatology · 2015 · 452 citations · Full text

Medicine, Oncology, Pharmacology +15

Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)

Luca Borradori, Nina van Beek, Claudio Feliciani et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 253 citations · Full text

Medicine, Dermatology, Pathology +16

DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics

Alfonso Latorre, Christian Posch, Yolanda Garcimartín et al. · Nanoscale · 2014 · 78 citations

Pharmacy, Oncology, Pharmaceutics +17

Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma

Martina Sanlorenzo, Aditi Choudhry, Igor Vujic et al. · Journal of the American Academy of Dermatology · 2014 · 78 citations · Full text

Medicine, Dermatology, Oncology +13

The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients

Christian Posch, Babak Itzinger-Monshi, Tamara Quint et al. · Journal of the American Academy of Dermatology · 2017 · 71 citations

Medicine, Surgery, Dermatologic Surgery +3